Menu

PhRMA's Karyn Schwartz, Alpine Group Partners' Shayne Woods and AHA's Bharath Krishnamurthy

PhRMA's Karyn Schwartz (left) and AHA's Bharath Krishnamurthy (right) debated the 340B program during a Feb. 5 panel moderated by Shayne Woods of Alpine Group Partners (center).

AHA, PhRMA Debate 340B at Summit Hosted by U.S. House Republican

February 10, 2026 William Newton, Associate Editor/Senior Writer 340B Report Views

Leading hospital and drug industry advocates clashed over the 340B program’s direction during a recent Washington, D.C., health care panel [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

CANN Targets State 340B Contract Pharmacy Access Bills in New Briefs; Draws Pushback From 340B Advocates

Pfizer to Require 340B Covered Entities to Sign Single Contract Pharmacy Attestation, Discontinue Previous Designations